Brain Cancer Drugs Market Research Reports

Market Spotlight: Neuroendocrine tumors (NET) - Product Thumbnail Image

Market Spotlight: Neuroendocrine tumors (NET)

  • Report
  • 42 Pages
From
Global Brain Cancer Partnering 2012 to 2018 - Product Thumbnail Image

Global Brain Cancer Partnering 2012 to 2018

  • Report
  • 150 Pages
From
Brain & CNS Cancer Forecast in 19 Major Markets 2016-2026 - Product Thumbnail Image

Brain & CNS Cancer Forecast in 19 Major Markets 2016-2026

  • Report
  • 66 Pages
From
Glioblastoma Multiforme: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis - Product Thumbnail Image

Glioblastoma Multiforme: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

  • Drug Pipelines
  • 144 Pages
From
Glioma Drug Profiles and Clinical Trials - Global Trends and Analysis Review, H1 2018 - Product Thumbnail Image

Glioma Drug Profiles and Clinical Trials - Global Trends and Analysis Review, H1 2018

  • Report
  • 540 Pages
From
High Grade Glioma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H1 2018 - Product Thumbnail Image

High Grade Glioma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H1 2018

  • Report
  • 177 Pages
From
Low Grade Glioma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H1 2018 - Product Thumbnail Image

Low Grade Glioma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H1 2018

  • Report
  • 90 Pages
From
Malignant Glioma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H1 2018 - Product Thumbnail Image

Malignant Glioma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H1 2018

  • Report
  • 205 Pages
From
Pontine Glioma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H1 2018 - Product Thumbnail Image

Pontine Glioma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H1 2018

  • Report
  • 100 Pages
From
CAS Methotrexate World Consumption Report - Product Thumbnail Image

CAS Methotrexate World Consumption Report

  • Report
  • 2095 Pages
CAS Cyclophosphamide World Consumption Report - Product Thumbnail Image

CAS Cyclophosphamide World Consumption Report

  • Report
  • 2091 Pages
CAS 59-05-2 Methotrexate Chemical World Report - Product Thumbnail Image

CAS 59-05-2 Methotrexate Chemical World Report

  • Report
  • 2111 Pages
CAS 6055-19-2 Cyclophosphamide monohydrate Chemical World Report - Product Thumbnail Image

CAS 6055-19-2 Cyclophosphamide monohydrate Chemical World Report

  • Report
  • 2001 Pages
CAS 7413-34-5 Sodium methotrexate Chemical World Report - Product Thumbnail Image

CAS 7413-34-5 Sodium methotrexate Chemical World Report

  • Report
  • 2006 Pages
CAS 15663-27-1 Cisplatin Chemical World Report - Product Thumbnail Image

CAS 15663-27-1 Cisplatin Chemical World Report

  • Report
  • 2157 Pages
CAS 159351-69-6 Everolimus Chemical World Report - Product Thumbnail Image

CAS 159351-69-6 Everolimus Chemical World Report

  • Report
  • 2075 Pages
CAS 50-18-0 Cyclophosphamide Chemical World Report - Product Thumbnail Image

CAS 50-18-0 Cyclophosphamide Chemical World Report

  • Report
  • 2011 Pages
Oligodendroglioma - Pipeline Insight, 2018 - Product Thumbnail Image

Oligodendroglioma - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Medulloblastoma - Pipeline Insight, 2018 - Product Thumbnail Image

Medulloblastoma - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Neuroblastoma - Pipeline Insight, 2018 - Product Thumbnail Image

Neuroblastoma - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Loading Indicator

With low survival rates primary brain cancers such as glioblastoma multiforme (the most common and aggressive of malignant brain tumours) are among the deadliest forms of cancer. Drug development activity is therefore intense in this sector, with resulting business development opportunities. Reports in the Brain Cancer section enable you to explore various facets of the industry from a variety of expert viewpoints, including R&D (clinical trials, drug discovery, etc.), competitive landscape, supply and demand, regional markets, regional market analysis, and much more. Show Less Read more

adroll